CatalystFDA/Bio

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen

Phase 3 topline update from Novartis partnership signals material clinical milestone.

What changed

Phase 3 topline update from Novartis partnership signals material clinical milestone.

Why it matters

Phase 3 topline update from Novartis partnership signals material clinical milestone. — impact context not separately stored; see What changed.

Sources